Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: J Immunol. 2008 Nov 1;181(9):6435–6446. doi: 10.4049/jimmunol.181.9.6435

Figure 1.

Figure 1

Decreased recognition of the methionine variant (Mp5) of the HLA A*0201 restricted T-cell epitope NS31406 is not due to loss of antigen processing and presentation or masking of low level responses. A. IFN-γ ELISpot was performed using PBMC obtained from Subject 28 one year following HCV infection when Mp5 was the dominant form of virus. Responses for PBMC incubated with the LP5 peptide (circles), which was present upon initial viremia, and Mp5 peptide (triangles), which was dominant six months following infection demonstrate decreased recognition of the Mp5 variant. B. Constructs containing either the Lp5 or Mp5 sequence were introduced via electroporation into EBV transformed cells from Subject 28. Immunogenicity of the construct-containing EBV cells (Black bars labeled mRNA) was assessed via intracellular cytokine staining (ICS) for IFN-γ using NS31406 specific-T cell lines generated from Subject 28. As a positive control, the same T cell line was tested for recognition of Lp5 and Mp5 peptides pulsed onto the surface of the autologous EBV transformed cells (Gray bars labeled peptide pulsed). There was no recognition of mock transfected EBV transformed cells (Black Control) or EBV transformed cells not pulsed with peptide (Grey Control). Recognition of the constructs as well as control constructs known not to represent processing mutations were similar to recognition when the peptides were pulsed onto the cell surface at a concentration of 0.001M, indicating that the Mp5 substitution did not prevent processing.